Healthcare Services

One of the Major Drivers of the Biologics Contract Development Market Is the Surge In Chronic Diseases Drives Demand, Fueling Growth In The Biologics Contract Development Market

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Biologics Contract Development Market At The End Of The 2026–2030 Forecast Period?

The biologics contract development market has experienced rapid expansion in recent years. Its value is forecast to increase from $8.55 billion in 2025 to $9.53 billion in 2026, with a compound annual growth rate (CAGR) of 11.4%. The growth observed in the historic period can be attributed to the increasing biologics pipeline complexity, rising costs of in-house manufacturing, expansion of monoclonal antibody development, growth of early-stage biologics research, and an increasing reliance on specialized cdmos.

The biologics contract development market size is anticipated to experience substantial growth in the upcoming years. It is forecast to expand to $14.46 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.0%. This projected expansion during the forecast period stems from factors such as increasing demand for rapid biologics scale-up, greater investments in advanced mammalian cell platforms, the broadening of oncology biologics pipelines, a heightened focus on flexible manufacturing capacity, and the rising adoption of digital bioprocess optimization. Significant trends expected in this period include increased outsourcing of biologics process development, growing demand for scalable cell line development, wider integration of single-use bioprocessing systems, the expansion of integrated CDMO service models, and an intensified emphasis on accelerating speed-to-clinic development.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp

Which Market Drivers Are Supporting The Expansion Of The Biologics Contract Development Market?

The increasing occurrence of chronic illnesses is anticipated to propel the biologics contract development market into the future. Chronic diseases are defined as conditions persisting for a year or more, necessitating continuous medical care. An uptick in chronic illness instances escalates the need for creating new medications, such as biologics, consequently fostering the biologics contract development market. As an illustration, reports released by the Office for Health Improvement & Disparities, a UK-based government, in September 2024, indicated that during the first half of 2023, 3,940 excess deaths were linked to chronic lower respiratory diseases, representing a 30% rise over anticipated figures. Over the full year, this figure climbed to 5,363, demonstrating a 22% overall surge. Consequently, the growing frequency of chronic diseases is set to fuel the expansion of the biologics contract development market.

What Segment Types Make Up The Biologics Contract Development Market?

The biologics contract development market covered in this report is segmented –

1) By Source: Microbial, Mammalian, Other Sources

2) By Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Other Indications

3) By Product Service: Cell Line Development, Process Development, Other Product Services

Subsegments:

1) By Microbial: Bacterial Sources, Yeast Sources, Fungal Sources

2) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Hybridoma Cells

3) By Other Sources: Plant-Based Systems, Insect Cell Systems, Algal Sources

What Industry Trends Are Redefining The Biologics Contract Development Market?

Major companies engaged in biologics contract development are increasingly concentrating on embedding data analytics into their development processes. These firms are integrating digital technologies and data analytics within biologics development to improve process monitoring, data analysis, and informed decision-making, which consequently enhances efficiency and productivity. A notable example occurred in October 2023, when WuXi Biologics, a China-based biologics contract development and manufacturing company, introduced its WuXiUI high-productivity bioprocessing platform. WuXiUI represents WuXi Biologics’ proprietary ultra-intensified intermittent-perfusion fed-batch platform, which has been successfully developed and applied both internally and in biologics development and manufacturing projects for clients. This platform notably enables real-time observation of critical process parameters via integrated Process Analytical Technology tools, optimizes cell culture productivity, and predicts product quality and yield profiles under various process conditions, contingent on suitable process data inputs.

Who Are The Key Players Driving Competition In The Biologics Contract Development Market?

Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Syngene International Limited, Vibalogics GmbH, Yposkesi

Read the full biologics contract development market report here:

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

How Is The Biologics Contract Development Market Distributed Across Key Geographic Regions?

North America was the largest region in the biologics contract development market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biologics Contract Development Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8219&type=smp

Browse Through More Reports Similar to the Global Biologics Contract Development Market 2026, By The Business Research Company

Biologics Outsourcing Global Market Report

https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

Biologics Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Biopharmaceuticals Contract Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795